This document discusses various in vitro and in vivo models for screening antipsychotic drugs. It begins by providing background on schizophrenia and antipsychotic drugs. It then describes two important in vitro models - the D1 receptor assay using 3H-SCH 23390 binding and the D2 receptor assay using 3H spiroperidol binding. Both assays are used to determine binding affinity of test compounds to dopamine receptors. Three key in vivo models are also outlined - the open field test to evaluate motor activity, the rota rod test to assess motor coordination, and the grip strength test to measure muscular strength. The document provides details on the procedures and evaluation of these screening models.
Introduction to Screening Models of Anti-Atherosclerosis
Atherosclerosis, Screening models, In vitro models, In vivo models
Presented by
SHAIK FIRDOUS BANU
Department of Pharmacology
Pharmacological screening of Anti-psychotic agentsAbin Joy
Presentation contents are:
Introduction, Definition of psychosis, Classification of anti-psychotics, MOA of anti-psychotic agents and screening models.
Preclinical Screening of Antiasthmatic DrugsShubham Kolge
Bronchial asthma is characterized by both bronchoconstriction and airway inflammation which leads to bronchial hyperresponsiveness to various stimuli. Different mediators are implicated in asthma. As the precise etiology is not known and multiple biochemical processes are triggered by different causative factors, it is difficult to have a single drug which can effectively and simultaneously act upon different mediators. This led to an intense search for potent and safe antiasthmatic drugs. This presentation intends to compile different screening methods for the evaluation of new candidate drugs with potential for the treatment of asthma. These include in vitro, in vivo, receptor binding and enzymatic methods.
Introduction to Screening Models of Anti-Atherosclerosis
Atherosclerosis, Screening models, In vitro models, In vivo models
Presented by
SHAIK FIRDOUS BANU
Department of Pharmacology
Pharmacological screening of Anti-psychotic agentsAbin Joy
Presentation contents are:
Introduction, Definition of psychosis, Classification of anti-psychotics, MOA of anti-psychotic agents and screening models.
Preclinical Screening of Antiasthmatic DrugsShubham Kolge
Bronchial asthma is characterized by both bronchoconstriction and airway inflammation which leads to bronchial hyperresponsiveness to various stimuli. Different mediators are implicated in asthma. As the precise etiology is not known and multiple biochemical processes are triggered by different causative factors, it is difficult to have a single drug which can effectively and simultaneously act upon different mediators. This led to an intense search for potent and safe antiasthmatic drugs. This presentation intends to compile different screening methods for the evaluation of new candidate drugs with potential for the treatment of asthma. These include in vitro, in vivo, receptor binding and enzymatic methods.
This file includes the general introduction to Alzheimer's, histopathology and Pharmacological treatment of Alzheimer's, preclinical screening models used in Alzheimer's. I hope this file may useful to life science students
Assignment on Preclinical Screening of ImmunomodulatorsDeepak Kumar
Assignment on Preclinical screening of new substances for the pharmacological activity using in vivo, in vitro, and other possible animal alternative models
In this slide contains diabetics, classification, symptoms, complication, invivo and invitro screening models of anti diabetics.
Presented by: GEETHANJALI ADAPALA (Department of pharmacology).
RIPER, anantapur
Screening Methods for behavioural and muscle Coordinationpradnya Jagtap
Screening Methods for behavioural and muscle Coordination
A. Motor activity and behaviour
1. Method of intermittent observation
2.Open field test
3.Hole board test
4.Combined open field test
B.Test for muscle coordination
1.Inclined plane method
2.Chimny test
3.Grip strength
4.Rotarod method
Preclinical Screening for Neurodegenerative Disease (Multiple Sclerosis)Drx Burade
This file includes introduction to multiple sclerosis (MS) , their sign and symptoms , types of multiple sclerosis, pathophysiology of MS , again this includes the medication that are used to treat MS , & the last point is the Preclinical Screening models or methods for multiple sclerosis . Preclinical Screening models includes in vivo and in vitro models
This file includes the general introduction to Alzheimer's, histopathology and Pharmacological treatment of Alzheimer's, preclinical screening models used in Alzheimer's. I hope this file may useful to life science students
Assignment on Preclinical Screening of ImmunomodulatorsDeepak Kumar
Assignment on Preclinical screening of new substances for the pharmacological activity using in vivo, in vitro, and other possible animal alternative models
In this slide contains diabetics, classification, symptoms, complication, invivo and invitro screening models of anti diabetics.
Presented by: GEETHANJALI ADAPALA (Department of pharmacology).
RIPER, anantapur
Screening Methods for behavioural and muscle Coordinationpradnya Jagtap
Screening Methods for behavioural and muscle Coordination
A. Motor activity and behaviour
1. Method of intermittent observation
2.Open field test
3.Hole board test
4.Combined open field test
B.Test for muscle coordination
1.Inclined plane method
2.Chimny test
3.Grip strength
4.Rotarod method
Preclinical Screening for Neurodegenerative Disease (Multiple Sclerosis)Drx Burade
This file includes introduction to multiple sclerosis (MS) , their sign and symptoms , types of multiple sclerosis, pathophysiology of MS , again this includes the medication that are used to treat MS , & the last point is the Preclinical Screening models or methods for multiple sclerosis . Preclinical Screening models includes in vivo and in vitro models
Preclinical Screening for Neurodegenerative Disease (Parkinsonism)Drx Burade
This file includes the general introduction of Parkinson's, sign and symptoms of Parkinson's, treatment of Parkinson's and the main content that is the Preclinical Screening models for Neurodegenerative disease like Parkinson's
The current slide focuses on different screening models for neurodegenerative diseases along with a brief description of the diseases where the slides are to the points and brief with detailed evaluation.
Acetabularia Information For Class 9 .docxvaibhavrinwa19
Acetabularia acetabulum is a single-celled green alga that in its vegetative state is morphologically differentiated into a basal rhizoid and an axially elongated stalk, which bears whorls of branching hairs. The single diploid nucleus resides in the rhizoid.
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...Levi Shapiro
Letter from the Congress of the United States regarding Anti-Semitism sent June 3rd to MIT President Sally Kornbluth, MIT Corp Chair, Mark Gorenberg
Dear Dr. Kornbluth and Mr. Gorenberg,
The US House of Representatives is deeply concerned by ongoing and pervasive acts of antisemitic
harassment and intimidation at the Massachusetts Institute of Technology (MIT). Failing to act decisively to ensure a safe learning environment for all students would be a grave dereliction of your responsibilities as President of MIT and Chair of the MIT Corporation.
This Congress will not stand idly by and allow an environment hostile to Jewish students to persist. The House believes that your institution is in violation of Title VI of the Civil Rights Act, and the inability or
unwillingness to rectify this violation through action requires accountability.
Postsecondary education is a unique opportunity for students to learn and have their ideas and beliefs challenged. However, universities receiving hundreds of millions of federal funds annually have denied
students that opportunity and have been hijacked to become venues for the promotion of terrorism, antisemitic harassment and intimidation, unlawful encampments, and in some cases, assaults and riots.
The House of Representatives will not countenance the use of federal funds to indoctrinate students into hateful, antisemitic, anti-American supporters of terrorism. Investigations into campus antisemitism by the Committee on Education and the Workforce and the Committee on Ways and Means have been expanded into a Congress-wide probe across all relevant jurisdictions to address this national crisis. The undersigned Committees will conduct oversight into the use of federal funds at MIT and its learning environment under authorities granted to each Committee.
• The Committee on Education and the Workforce has been investigating your institution since December 7, 2023. The Committee has broad jurisdiction over postsecondary education, including its compliance with Title VI of the Civil Rights Act, campus safety concerns over disruptions to the learning environment, and the awarding of federal student aid under the Higher Education Act.
• The Committee on Oversight and Accountability is investigating the sources of funding and other support flowing to groups espousing pro-Hamas propaganda and engaged in antisemitic harassment and intimidation of students. The Committee on Oversight and Accountability is the principal oversight committee of the US House of Representatives and has broad authority to investigate “any matter” at “any time” under House Rule X.
• The Committee on Ways and Means has been investigating several universities since November 15, 2023, when the Committee held a hearing entitled From Ivory Towers to Dark Corners: Investigating the Nexus Between Antisemitism, Tax-Exempt Universities, and Terror Financing. The Committee followed the hearing with letters to those institutions on January 10, 202
Biological screening of herbal drugs: Introduction and Need for
Phyto-Pharmacological Screening, New Strategies for evaluating
Natural Products, In vitro evaluation techniques for Antioxidants, Antimicrobial and Anticancer drugs. In vivo evaluation techniques
for Anti-inflammatory, Antiulcer, Anticancer, Wound healing, Antidiabetic, Hepatoprotective, Cardio protective, Diuretics and
Antifertility, Toxicity studies as per OECD guidelines
Synthetic Fiber Construction in lab .pptxPavel ( NSTU)
Synthetic fiber production is a fascinating and complex field that blends chemistry, engineering, and environmental science. By understanding these aspects, students can gain a comprehensive view of synthetic fiber production, its impact on society and the environment, and the potential for future innovations. Synthetic fibers play a crucial role in modern society, impacting various aspects of daily life, industry, and the environment. ynthetic fibers are integral to modern life, offering a range of benefits from cost-effectiveness and versatility to innovative applications and performance characteristics. While they pose environmental challenges, ongoing research and development aim to create more sustainable and eco-friendly alternatives. Understanding the importance of synthetic fibers helps in appreciating their role in the economy, industry, and daily life, while also emphasizing the need for sustainable practices and innovation.
Introduction to AI for Nonprofits with Tapp NetworkTechSoup
Dive into the world of AI! Experts Jon Hill and Tareq Monaur will guide you through AI's role in enhancing nonprofit websites and basic marketing strategies, making it easy to understand and apply.
Embracing GenAI - A Strategic ImperativePeter Windle
Artificial Intelligence (AI) technologies such as Generative AI, Image Generators and Large Language Models have had a dramatic impact on teaching, learning and assessment over the past 18 months. The most immediate threat AI posed was to Academic Integrity with Higher Education Institutes (HEIs) focusing their efforts on combating the use of GenAI in assessment. Guidelines were developed for staff and students, policies put in place too. Innovative educators have forged paths in the use of Generative AI for teaching, learning and assessments leading to pockets of transformation springing up across HEIs, often with little or no top-down guidance, support or direction.
This Gasta posits a strategic approach to integrating AI into HEIs to prepare staff, students and the curriculum for an evolving world and workplace. We will highlight the advantages of working with these technologies beyond the realm of teaching, learning and assessment by considering prompt engineering skills, industry impact, curriculum changes, and the need for staff upskilling. In contrast, not engaging strategically with Generative AI poses risks, including falling behind peers, missed opportunities and failing to ensure our graduates remain employable. The rapid evolution of AI technologies necessitates a proactive and strategic approach if we are to remain relevant.
Model Attribute Check Company Auto PropertyCeline George
In Odoo, the multi-company feature allows you to manage multiple companies within a single Odoo database instance. Each company can have its own configurations while still sharing common resources such as products, customers, and suppliers.
Read| The latest issue of The Challenger is here! We are thrilled to announce that our school paper has qualified for the NATIONAL SCHOOLS PRESS CONFERENCE (NSPC) 2024. Thank you for your unwavering support and trust. Dive into the stories that made us stand out!
Honest Reviews of Tim Han LMA Course Program.pptxtimhan337
Personal development courses are widely available today, with each one promising life-changing outcomes. Tim Han’s Life Mastery Achievers (LMA) Course has drawn a lot of interest. In addition to offering my frank assessment of Success Insider’s LMA Course, this piece examines the course’s effects via a variety of Tim Han LMA course reviews and Success Insider comments.
2. contents
❖Introduction
❖Clinical features of schizophrenia
❖Classification of antipsychotics
❖Pathophysiology of schizophrenia
❖Screening models for antipsychotics
2
Department of Pharmacology BVVS COP
BGK
3. Introduction
➢Antipsychotic are the drugs having therapeutic
effect in psychoses.
Psychoses
Functional
disorder
Cognitive
disorder
Ex: Schizophrenia Ex: Delirium, Dementia
3
Department of Pharmacology BVVS COP
BGK
4. Schizophrenia: It is a particular type of psychosis (that is
mental disorder caused by inherent dysfunction of the
brain).
➢ Symptoms are wide ranging and are found across
multiple cultural and ethnic group.
➢ It is characterized by delusions, hallucinations, and
thinking or speech disturbance.
➢Affects 1% of population.
➢Affects young and old.
➢Affects men and women equally.
➢Chronic and disabling disease.
4
Department of Pharmacology BVVS COP
BGK
5. ❖ETIOLOGY
➢Genetic predisposition (10%)
➢ Prenatal (viral infections)
➢Prenatal (oxygen deprivation)
➢Postnatal (CNS infections)
➢Stress in adolescence
5
Department of Pharmacology BVVS COP
BGK
8. ❖PATHOPHYSIOLOGY OF SCHIZOPHRENIA
❖Neurophysiological theory
➢ Dopamine theory
➢ Serotonin theory
➢ Glutamate theory
❖Dopamine theory
➢ Abnormal increase in dopamine
❖Hypo frontal hypothesis:
➢ Increase DA in mesolimbic site of brain
➢ Decrease DA in frontal, pre-frontal & the temporal
❖Cervices → Decrease metabolic activity
❖Other reason are increase serotonin (5HT, glutamate)
8
Department of Pharmacology BVVS COP
BGK
9. ➢The psychosis behaviour mainly occurs due to excessive
release of Dopamine at D2 receptors.
No consistent bio-chemical evidence for excessive
dopamine synthesis or release.
➢The mesolimbic system is a dopaminergic tract that
originates in the ventral tegmental area (VTA) and projects
to the nucleus accumbens, ventral striatum, parts of the
hippocampus, and other components of the limbic system.
➢It involve the development of emotions & memory, and
some hypothesize that mesolimbic hyperactivity is
responsible for the positive symptoms of schizophrenia.
DOPAMINE THEORY
9
Department of Pharmacology BVVS COP
BGK
12. IN VITRO MODELS IN VIVO MODELS
1) D1 receptor assay ³H –SCH 23 390
binding to rat striatal homogenates.
2) D2 receptor assay ³H spiroperidol
binding
3) D2 receptor auto radiography
³H spiperone binding
4) Binding to the D3 and D4 receptor
5) Determination of dopamine auto
receptor activity.
6) α1 adrenergic receptor binding in
brain
7) Serotonin 5HT receptor
autoradiography.
8) Binding to the sigma receptor.
9) Measurement of neurotransmitters
by intracranial micro-dialysis.
10)Simultaneous determination of
nor-epineprine, dopamine, DOPAC,
HVA, 5HIAA.
1) Golden hamster test
2) Influence on behavior of the
cotton rat
3) Open field test
4) Brain self stimulation.
5) Rota rod method
6) Amphetamine group toxicity
7) Inhibition of mouse jumping
8) Pole climb avoidance in rats.
9) Artificial hibernation in rats.
10) Grip strength
12
Department of Pharmacology BVVS COP
BGK
13. IN VITRO MODELS
➢ D1 Receptor Assay
(³H- SCH 23 390 binding to rat stratial homogenates)
➢D2 Receptor assay
(³H spiroperidol binding)
13
Department of Pharmacology BVVS COP
BGK
14. PURPOSE AND RATIONAL
➢Dopamine receptor are the primary targets in the development of drugs for the
treatment of schizophrenia, Parkinson’s diseases.
➢Multiple dopamine receptors are know. Designated as D1 and D2.
D1A
D1
DOPAMINE D2B
D2 D2S
D3 D2L
D5 D4
D1 Receptor assay
³H-SCH23390 Binding rat striatal homogenates
14
Department of Pharmacology BVVS COP
BGK
15. ➢For typical neuroleptic agents, Haloperidol, good correlation
was found between D2 receptor binding and clinically
effective doses.
➢A typical neuroleptics, like clozapin, were found to be potent
inhibitors of D1 and D4 receptor binding, renewing interest
in these receptor types.
➢The compound SCH 23390 was found to be selective for
the D1 receptor.
15
Department of Pharmacology BVVS COP
BGK
16. ❖ PROCEDURE
➢REAGENTS:
➢d-Butaclamol a 1 mM stock solution is made and diluted
1:20.
➢ 20 µl are added to 3 tubes for the determination of
nonspecific binding.
➢ For the test compounds a 1 mM stock solution is made
up in a suitable solvents and serially diluted, such that the
final concentration in the assays ranges from 10ˉ⁵ to 10ˉ⁸M.
16
Department of Pharmacology BVVS COP
BGK
17. ❖Tissue preparation
Male Wister rates
decapitated, striate dissected.
Brains rapidly removed and weighed
The striata are homogenized in 100 volumes of 0.05 M tris buffer,
Mantained pH 7.7 using a Tekmar homogenizer.
centrifused at 40,000g for 20 min
The final pellet is re-suspended in the original volume of 0.05M Tris
buffer, pH 7.7, containing physiological ions
(NaCl 120mM, KCl 5mM, MgCI2 1mM and CaCl2 2mM).
17
Department of Pharmacology BVVS COP
BGK
18. ❖ASSAY
➢50µl 0.5 M Tris buffer, pH 7.7, containing physiological
ions. 380µl H₂O, 20µl vehicle or d-butaclamol or
appropriate concentration of test compound.
➢5oµl 3H- SCH23390
➢500µl tissue suspension.
➢ The tubes are incubated at 37ºC for 30 min.
➢The assay is stopped by rapid filtration through
whatman’s GF/B filters using a brand-ell cell harvester.
➢The filter strips are then washed 3 times with ice-cold
0.05M this buffer, pH7.7, and counted in 10ml Liquiscint
scintillation cocktail.
18
Department of Pharmacology BVVS COP
BGK
19. ❖EVALUATION
➢Specific binding is defined as the difference between total
binding in the presence of 1µM d-butaclamol.
➢ IC50 calculations are performed using log-Probit
analysis.
19
Department of Pharmacology BVVS COP
BGK
20. ❖D2 RECEPTOR ASSAY: (³H) spiroperidol binding
❖PURPOSE AND RATIONALE
➢The neuroleptic compound haloperidol has been used as
binding ligand to study the activity of other neuroleptics.
➢ The use of haloperidol has been superseded by
spiroperidol.
➢Dopamine receptor binding assays employing
dopaminergic antagonists in mammalian striatal tissue,
dopamine enriched area of the brain, have been shown to be
predictive of in vivo dopamine receptor antagonism and
antipsychotic activity.
20
Department of Pharmacology BVVS COP
BGK
21. ❖TISSUE PREPARATION
Male rats decapitated
striata removed and weighed
Homogenized in 50 volumes of ice cold 0.05M tris buffer ,
Ph 7.7
Then centrifuged at 40,000g for15 min
Again that pellets were re-centrifuse at 40,000g
Then the final pellets were re-suspended in Tris buffer
(physiological salt) resulting in a concentration of 10mg/ml.
21
Department of Pharmacology BVVS COP
BGK
22. ❖ASSAY
The membrane preparation took
Incubated with ³H spiroperidol (0.25nm) and various concentration of
test drug at 37ºc for 20 min k/Na phosphate buffer.
Cooling in an ice bath for 45min
Bound ligand is separated by rapid filtration
Filters are washed 3 times with ice cold water
Dry it and shaken through with 3.5ml scintillation fluid
From the liquid scintillation counter radio activity is determined.
22
Department of Pharmacology BVVS COP
BGK
23. ❖EVALUATION
From this assay
The following parameters are determined
✓Total binding of ³H spiroperidol
✓Non specific binding: binding of samples containing
2mM butaclamol
✓Specific binding = total binding – non specific binding
✓% inhibition :100- specific binding as % of control value.
23
Department of Pharmacology BVVS COP
BGK
24. IN VIVO MODELS
➢Open field test
➢Rota road method
➢ Grip strength
24
Department of Pharmacology BVVS COP
BGK
25. ❖Purpose and Rationale:
➢ Interruption of light beams as a measure of movements
of rats and mice in a cage (“open field”).
❖Procedure:
➢ Rats are observed in a square open field equipped with 2
rows of 8 photo cells, sensitive to IR.
➢ The photo cells are placed apart from each other and the
last photo cell in a row is spaced 25mm from the wall.
➢ Measurements are made in a ventilated, sound-
attenuating box.
➢ Interruptions of photocell beams can be collected by
micro-computer as follows
❖OPEN FIELD TEST
25
Department of Pharmacology BVVS COP
BGK
26. ➢Motor activity: All interruptions of photo beams in the
lower rows.
➢Peripheral motor activity: Activation of photo beams in
the lower rows, provided that the photo beams from the wall
were collected.
➢Rearing: All the interruption of the photo beams in the
upper rows.
➢Locomotion: Successive interruptions of photo cells in the
lower rows, when the animal is moving in the same
direction.
➢Speed: The time between successive photo beam
interruptions during locomotion collected in 0.1s categories.
26
Department of Pharmacology BVVS COP
BGK
28. ❖Evaluation:
➢Dose response curves can be obtained for sedative &
stimulant drugs, whereas the various parameters show
different results.
➢The effects of various drugs are compared statistically
with the values of controls & among themselves.
❖Modifications:
➢Besides interruption of light beams, devices based on
capacitance systems have been developed.
28
Department of Pharmacology BVVS COP
BGK
29. ❖Purpose and Rationale:
➢ The test is used to evaluate the activity of the drugs
interfering with motor co-ordination which suggests that
the skeletal muscle relaxation induced by an compound.
❖Procedure:
➢ Its an horizontal wood or metal rod coat with rubber.
➢ The rod is divided into 6 sections by plastic discs, there by
allowing simultaneous testing of 6 mice.
➢ Rod is placed at an certain height above the table in order to
discourage the animals from jumping off the roller.
➢ Cages, below placed serves to place the animals, whenever
they fell down.
➢ Trained animals are selected. The test compounds are
administered either by oral or i.p.
❖Rota rod Method
29
Department of Pharmacology BVVS COP
BGK
31. ➢ Mice are placed on the rod for 1min after administration
of drug.
➢ The number of animals falling down are noted along
with the time.
➢ ED50 is calculated by using different doses.
❖Calculation:
➢ % animals falling from the rota rod with the test period
is calculated for every drug concentration tested.
31
Department of Pharmacology BVVS COP
BGK
32. ❖Grip strength:
❖PURPOSE AND RATIONALE:
➢ The test is being used to assess muscular strength or
Neuromuscular function in rodents.
❖PROCEDURE:
➢ Male or female mice are used.
➢ In a preliminary experiment the animals are tested for
their normal reactivity.
➢ The animals are exposed to a horizontal thin threat or
metallic wire suspended about 30 cm into the air which
they immediately grasp with the forepaws.
➢ The mouse is released to hang on with its forelimbs.
32
Department of Pharmacology BVVS COP
BGK
33. ➢ Normal animals are able to catch the threat with the hind limbs and
to climb up within 5s.
➢ Only animals who fulfil this criterion are included into the
experiment.
➢ Ten mice are used in the control group and in the experimental
groups.
➢ Animals are tested every15 min.
➢ Animals which are not able to touch the threat with the hind limbs
within 5s or fall off from the threat are considered to be impaired.
➢ The test is continued for 2 hrs.
➢ The animals are observed for their behaviour in the cages.
➢ Only if their behaviour and their motility in the cage seem to be
normal the disturbance of the grasping reflex can be considered as
caused by central relaxation.
33
Department of Pharmacology BVVS COP
BGK
35. ❖References
➢ Drug Discovery & Evaluation Pharmacological assay
– H. G. Vogel
➢ Rang and Dale Pharmacology sixth edition H. P. Rang,
M. M. Dale J. M. Ritter R. J. Flower
➢ Goodman and Gilman`s Manual of Pharmacology and
Therapeutics
35
Department of Pharmacology BVVS COP
BGK